Integrum AB (OSTO:INTEG B) Research & Development: kr0.00 Mil (TTM As of Apr. 2026)


OSTO:INTEG B Integrum AB OSTO:INTEG B
53 GF Score
Price kr8.22
GF Value kr17.76
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB Research & Development?

Integrum AB OSTO:INTEG B +0.24% 53 Research & Development is kr0.00 Mil as of Apr. 2026. GuruFocus rates OSTO:INTEG B with a GF Score™ of 53/100 and a GF Value™ of kr17.76 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Integrum AB's Research & Development for the three months ended in Apr. 2026 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was kr0.00 Mil.

Integrum AB  (OSTO:INTEG B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Integrum AB Research & Development Related Terms

Integrum AB Research & Development Historical Data

* Premium members only.

The historical data trend for Integrum AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB Research & Development Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Integrum AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:INTEG B
53GF Score
Integrum AB OSTO:INTEG B
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of kr0.00 Mil mean?
Integrum AB (OSTO:INTEG B) has a Research & Development of kr0.00 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on Integrum AB and its competitors.
Is Integrum AB's Research & Development too high?
Integrum AB's current Research & Development is kr0.00 Mil. Overall, Integrum AB has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Research & Development compare to ABT and SYK?
Integrum AB's Research & Development of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Integrum AB and its competitors. Integrum AB's current Research & Development is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.76, compared to a current price of kr8.22 — trading 53.7% below its estimated fair value. The current Research & Development is kr0.00 Mil. Integrum AB's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current Research & Development is kr0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of kr8.22 is trading 53.7% below its estimated GF Value™ of kr17.76. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for OSTO:INTEG B:

  • Research & Development: kr0.00 Mil
  • GF Value™: kr17.76 vs. price of kr8.22 (53.7% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrum AB Business Description

Other Exchanges 6Y1:Germany
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
53GF Score

Get the complete analysis for OSTO:INTEG B

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.22
Price
kr17.76
GF Value